High expression of PITPNM3 significantly predicts poor prognosis of breast cancer in TCGA BRCA, KM plotter BRCA, bc‐GenExMiner BRCA and marginally predicts poor overall survival of breast cancer in SYSU cohort (Figure 1A,B). Here, PITPNM3 is linked to breast carcinoma.